Drug · DIN 02308029
MIRCERA
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 27, 2017.
- Drug Identification Number (DIN)
- 02308029
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous; Intravenous
- Therapeutic class (ATC)
- Methoxy polyethylene glycol-epoetin beta B03XA03
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 300 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 31, 2008: NOC 9461New Drug Submission (NDS)
Other DINs named MIRCERA
- DIN 02307995 · Cancelled Pre Market
- DIN 02308002 · Cancelled Pre Market
- DIN 02308010 · Cancelled Pre Market
- DIN 02308037 · Cancelled Pre Market
- DIN 02308045 · Cancelled Pre Market
- DIN 02308053 · Cancelled Pre Market
- DIN 02308061 · Cancelled Pre Market
- DIN 02308088 · Cancelled Pre Market
- DIN 02308096 · Cancelled Pre Market
- DIN 02308118 · Cancelled Pre Market
- DIN 02308126 · Cancelled Pre Market
- DIN 02308134 · Cancelled Pre Market
- DIN 02308142 · Cancelled Pre Market
- DIN 02308150 · Cancelled Pre Market